The abstract submission process is now closed.
- Abstract withdrawal requests should be emailed to Andrea Van Hoever at ASE Headquarters. Be sure to include your abstract’s title and the presenting author’s information in your request.
Questions? Contact Andrea Van Hoever at ASE Headquarters.
|Friday, August 23, 2013||Submission opens|
|Sunday, November 17, 2013
(11:59 PM Eastern Standard Time)
|Deadline for abstract submission|
|Tuesday, November 26, 2013||Notification to Presenting Authors of acceptance status|
|Monday, January 20 – Friday, January 24, 2014||24th Annual Echo Hawaii|
|Wednesday, January 22, 2014||Poster Session and Reception from 5 pm-6 pm|
Why Submit Your Science to ASE?
Abstract presenters at the 24th Annual Echo Hawaii receive:
- Support – Presenting authors are eligible for a $100 discount on their conference registration fee.
- Awareness – Accepted abstracts will be distributed onsite to course attendees and will be available on the conference web site after the meeting.
- Visibility – Experts in cardiovascular research will see your science, and the dedicated viewing time provides an opportunity to discuss your work with faculty and attendees.
Presentation Format – Moderated Poster
Submitted abstracts will be peer-reviewed by a panel of graders and selection for presentation based solely on scientific merit.
Accepted abstracts will be presented as a poster on the evening of Wednesday, January 22 and presenting authors will be required to attend their poster during the dedicated poster reception and viewing time. Members of the faculty will moderate your work, allowing you an opportunity to briefly present your key findings for commentary from our internationally-renowned faculty. A best poster prize will be awarded based on the moderators’ selection.
ASE will provide poster boards that measure four feet high (121 cm) and three feet wide (92 cm). Note that this poster board is smaller than those typically used at scientific sessions and is in “portrait” orientation.
SUBMISSION & PRESENTATION GUIDELINES
- Authors do not need to be ASE members to participate.
- Abstract submission is free of charge. However, any expenses (e.g., registration, airfare, lodging, etc.) associated with the submission and presentation of an abstract are the responsibility of the presenter.
- Presenting authors are eligible for a $100 discount on their conference registration fee.
- Submission of an abstract constitutes a commitment by the author(s) to present if accepted. Presenting authors will be expected to register for the 24th Annual Echo Hawaii meeting within two weeks of acceptance or risk forfeiting their presentation assignment.
Submission Details & Deadlines
- Abstract submission opens Friday, August 23, 2013.
- Abstracts must be submitted in their final form by 11:59 PM Eastern Standard Time on Sunday, November 17, 2013.
- Authors must follow all instructions for completing the online submission form.
- ASE is not responsible for work that is not submitted by the submission deadline. No new abstracts may be submitted after this deadline.
- After the submission deadline, abstracts will be forwarded to review.
- Submitted abstracts will be peer-reviewed by a panel of graders and selections for presentation will be based solely on scientific merit.
Abstract Preparation Guidelines
- If an author’s name appears on more than one abstract, it must be identical on each abstract.
- If an abstract is accepted for presentation, the presenter must be one of the authors listed on the work.
- Do not list authors by initials only.
Content and Format
- Character limit – Abstracts are limited to 500 words. This includes the text, but not the title or authors.
- Tables/Graphics – The use of up to two (2) tables and/or graphics are encouraged if they are relevant to the research submitted.
- Abbreviations – A maximum of five (5) unique abbreviations is allowed within the body of the abstract. No abbreviations should appear in the title. Place abbreviations in parentheses after the full word or phrase the first time it appears. Abbreviations increase the difficulty of reading and evaluating abstracts, which will be considered in the review process.
- Examples of proper abbreviations: 2D (not 2-D), 3D (not 3-D)
- Format – Content should be structured into the following four (4) sections:
- Clarity of expression will be considered in the review process. The overall quality of language used should assure comprehension by the reader.
- Do not include:
- References, credits or grant support.
- Names or personal information of any patient participating in the study or trial. If you do, the abstract will not be considered for presentation.
- Authors or institutions in the title.
- Proofread abstracts carefully to avoid errors. ASE will never edit the scientific content of a submission. Nor will it make grammatical changes to a submission, including typographical errors. If accepted, the abstract will be distributed exactly as submitted.
- Any human experimentation must conform with the principles of the Declaration of Helsinki of the World Medical Association.
- ASE endorses the position of the American Association for the Advancement of Science (AAAS) in requiring assurances of the responsible use of animals in research. All submissions for consideration must be in compliance with these guidelines (AAAS Resolution: Use of Animals in Research, Testing, and Education).
- The submitting author acts on behalf of all co-authors and in submitting an abstract for consideration, agrees that if accepted the work is embargoed for release until date and time of presentation at the 24th Annual Echo Hawaii. Information may not be released before then. Failure to honor the embargo policy will result in the abstract being withdrawn and barred from presentation.
- All presentations and question-and-answer periods will be in English. If presenters need assistance in understanding or responding to questions in English, they are encouraged to have a member of their research team assist them.
- Each presenting author is required to comply with the ASE Disclosure Policy and is expected to disclose to the audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing ical education activity. This pertains to relationships with pharmaceutical companies, bioical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic.
- The submitter acts on behalf of all co-authors and in submitting an abstract, transfers to ASE the copyright and all other rights in the material comprising the abstract if the abstract is accepted. Co-authors reserve the following:
- All proprietary rights other than copyright, such as patent rights;
- The right to use all or part of the abstract in future works of their own.
- ASE, as holder of the copyright of the accepted abstract, reserves all rights of reproduction, distribution, performance, display, and the right to create derivative works in both print and digital formats.
In light of increased attention to the manner in which research results (particularly those affecting the stock of publicly-traded companies) are made public, ASE is clarifying its policies and procedures regarding disclosure of abstracts.
- All abstracts submitted are disclosed to members of the peer-review selection committee, as well as to ASE employees and contractors as necessary in connection with the 24th Annual Echo Hawaii program. Notwithstanding these policies and procedures, ASE is not subject to any confidentiality requirements with respect to submitted abstracts. In addition, compliance with any disclosure or nondisclosure requirements that apply to researchers or research sponsors (whether under federal securities laws, contract agreement, or otherwise) is the sole responsibility of the researcher and/or sponsor, and not ASE.